Profound Medical to Participate in the Stifel 2025 Healthcare Conference
TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of di
(Financial Post, 2025-10-14T12:34:20Z)